SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001583648-18-000030
Filing Date
2018-05-10
Accepted
2018-05-10 07:46:16
Documents
7
Period of Report
2018-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm 8-K 24896
2 EXHIBIT 99.1 a180510pressrelease.htm EX-99.1 16333
3 a180510pressrelease001.jpg GRAPHIC 253075
4 a180510pressrelease002.jpg GRAPHIC 201177
5 a180510pressrelease003.jpg GRAPHIC 162274
6 a180510pressrelease004.jpg GRAPHIC 80265
7 a180510pressrelease005.jpg GRAPHIC 64013
  Complete submission text file 0001583648-18-000030.txt   1090896
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 18820544
SIC: 8731 Services-Commercial Physical & Biological Research